Jean Cho is the co-founder / CEO of Trevarx Biomedical. She has managed strategic planning, product planning, and marketing teams for the eCommerce, Office and consumer products at Microsoft Corporation and prior to that was an investment banker in corporate finance at Drexel, Burnham, Lambert, Inc. She graduated with an Economics-Political Science Degree from Yale University and an MBA from Harvard Business School.

Sally Schwarz is the Director of Chemical Development & Manufacturing and a Professor of Radiology at Washington University School of Medicine in St. Louis. She is a nuclear pharmacist and as a member of the United States Pharmacopeia Expert Committee, was involved in revising the US GMP PET production and quality control requirements for PET research radiopharmaceuticals. She is also a Past President of the Society of Nuclear Medicine and Molecular Imaging.

Aaron Dubberley is the Director of Intellectual Properties. He is a US patent attorney with 25 years of experience in pharma and biotech matters across a range of in-house, law firm and university tech-transfer positions. Aaron’s previous positions include Evrys Bio, Mount Sinai Innovation Partners, Organon and Hoffmann-La Roche.

Mary Pund is the Director of Finance and Accounting. Most recently, she managed accounting, budgeting, human resources and financial planning for the family office of a Seattle entrepreneur. Prior to that, she was CFO at Kinkos.com, an internet start-up subsidiary as well as Treasurer and VP of Corporate Development at the parent company, Kinkos, Inc. She spent over 10 years in investment banking and private equity with Drexel Burnham Lambert, Smith Barney and at Clayton, Dubilier & Rice.